Comparison of 2 Clostridium difficile surveillance methods: National Healthcare Safety Network's laboratory-identified event reporting module versus clinical infection surveillance

Infection Control and Hospital Epidemiology

Volumn 34, Issue 3, 2013, Pages 284-290

  Gase, Kathleen A ^a   Haley, Valerie B ^a   Xiong, Kuangnan ^a   Antwerpen, Carole Van ^a   Stricof, Rachel L ^a,b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b Council of State and Territorial Epidemiologists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL INFECTION SURVEILLANCE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DATA ANALYSIS; DATA BASE; DISEASE CONTROL; DISEASE SURVEILLANCE; HUMAN; INFECTION RATE; NATIONAL HEALTHCARE SAFETY NETWORK S LABORATORY IDENTIFIED EVENT REPORTING MODULE; VALIDATION STUDY;

EID: 84873622114     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/669509     Document Type: Article

References (21)

1. Bartlett JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med 2002;346:334-339.
2. McDonald LC, Owings M, Jernigan D. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006;12:409-415.
3. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004;189:1585-1589.
4. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624-631.
5. Redelings M, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007;13:1417-1419.
6. Lucado J, Gould C, Elixhauser A. Clostridium difficile Infections (CDI) in Hospital Stays, 2009. HCUP statistical brief no. 124. Rockville, MD: Agency for Healthcare Research and Quality, US Department of Health and Human Services, 2011. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf. Accessed April 2, 2012.
7. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012;55:216-223.
8. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short-and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46:497-504.
9. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140-145.
10. Multidrug-resistant organism and Clostridium difficile infection (MDRO/CDI) module. National Healthcare Safety Network website. http://www.cdc.gov/nhsn/mdro_cdad.html. Accessed January 10, 2012.
11. New York State Department of Health. Hospital-Acquired Infections: New York State 2010. Albany: New York State Department of Health, 2011. http://www.health.ny.gov/statistics /facilities/hospital /hospital_acquired_infections/2010/docs /hospital_acquired_infection.pdf. Accessed May 21, 2012.
12. Campbell RJ, Giljahn L, Machesky K, et al. Clostridium difficile in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009;30:526-533.
13. California Department of Public Health. Healthcare-Associated Clostridium difficile Infections in California Hospitals, January 2009 through March 2010. Sacramento: California Department of Public Health, 2011. http://www.cdph.ca.gov/programs/hai /Documents/HAIReportSB-1058Cdiff-FINAL.pdf. Accessed May 21, 2012.
14. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and FY 2012 rates; hospitals' FTE resident caps for graduate medical education payment. Centers for Medicare and Medicaid Services website. http://www.naph.org/Main-Menu-Category/Our-Work/Safety-Net-Financing /Medicare/IPPS/FY2012-Final-IPPS-Rule.aspx?FTp.pdf. Accessed April 2, 2012.
15. Koll BS, Ruiz RE, Calfee DP, et al. Prevention of hospital-onset Clostridium difficile infection in the New York metropolitan region using a collaborative intervention model. J Healthc Qual doi:10.1111/jhq.12002. Electronically published January 7, 2012.
16. SPARCS overview. New York State Department of Health website. http://www.health.ny.gov/statistics/sparcs/operations /overview.htm. Accessed September 12, 2011.
17. Little RJA, Rubin DB. Statistical Analysis with Missing Data. Hoboken, NJ: Wiley, 2002.
18. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-372.
19. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-2441.
20. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short-and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46:497-504.
21. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect 2012;18(3): 282-289.